Xuxa Meneghel

What happened after the listing

Espaçolaser listed on Brazil's B3 exchange on 1 February 2021 at R$17.90 a share, raising roughly R$2.6 billion, and the stock rose about 17% on its first day of trading. What followed is the part worth knowing. The shares fell steadily from there — down close to 59% against the IPO price by the end of that same year, and by 2026 the company's market value had shrunk by more than 95% from where it listed, to a few hundred million reais. Press reporting in 2026 described one of its large shareholders weighing an exit from the controlling block.

None of that reflects on Xuxa specifically. It is simply what happened to the company she is a shareholder in, and it is the kind of outcome that tends not to feature in coverage of celebrity partnerships.

Early partner and IPO buyer are not the same position

Xuxa became a partner in 2015, six years before the listing. That timing is the whole story of why her position and the position of someone who bought shares on day one are not comparable, even though both are described as owning the same company. She acquired her stake privately at a private-company price; IPO buyers paid R$17.90 in a public auction after years of growth had already been priced in.

This is the general shape of a listing: it is the moment early private holders gain the ability to sell, and public investors take the other side of that trade. Neither side is doing anything improper — it is how the mechanism is designed to work. But it does mean that reading "she is a shareholder" as a reason to buy the same shares confuses two entirely different entry points, years and a valuation apart.

Further reading: InfoMoney — Espaçolaser's B3 debut · Seu Dinheiro — shares down 95% since the IPO

If this made the sector interesting rather than the celebrity, start with how to begin investing — and, if private companies are what caught your eye, how angel investing actually works.